首页> 外文期刊>Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society >Genetic variability of hepatitis C virus NS3 protein in human leukocyte antigen-A2 liver transplant recipients with recurrent hepatitis C.
【24h】

Genetic variability of hepatitis C virus NS3 protein in human leukocyte antigen-A2 liver transplant recipients with recurrent hepatitis C.

机译:丙型肝炎复发的人类白细胞抗原-A2肝移植受者中丙型肝炎病毒NS3蛋白的遗传变异性。

获取原文
获取原文并翻译 | 示例
           

摘要

The association between the severity of chronic hepatitis C and the variability of the hepatitis C virus (HCV) genome remains controversial, but to our knowledge few data are available to date regarding T-cell epitope coding regions in transplant patients. In the current study, we identified 21 human leukocyte antigen (HLA)-A2-positive Spanish patients with chronic hepatitis C, 14 immunosuppressed liver transplant recipients, and 7 immunocompetent controls. Alanine aminotransferase, aspartate aminotransferase, viral load, and rate of fibrosis progression were determined. Genetic distances of HCV isolates and variations in epitopes of the HCV nonstructural 3 protein (NS3-1393 LIFCHSKKK and NS3-1406 KLVALGINAV) were compared between patients with slow or fast progression of fibrosis. Isolates from transplant patients with fast progression were found to be more divergent (P =.03), had a higher mean value of synonymous (dS) variations (P =.02), and some were differentiated in a phylogenetic tree, compared with isolates from patients with slow progression. The HLA-A2-restricted NS3-1406 epitope was found to be more variable (20 of 21 isolates differed from the prototype) compared with the A3-restricted NS3-1392 epitope (19% vs. 1.25% variation). A shift in the viral peptide was not detected in a subset of transplant patients, but was evident in two of three nontransplant patients with follow-up. There was no correlation noted between a particular amino acid variation and fibrosis progression (slow or fast) in either transplant or nontransplant patients. The results of the current study suggest that 1) there may be different HCV-1b strains in our geographic area, 2) immunosuppression appears to have little effect in amino acid variation at the HCV NS3-1406 epitope, and 3) variations over time might be more frequent in nonimmunosuppressed patients.
机译:慢性丙型肝炎的严重程度与丙型肝炎病毒(HCV)基因组变异之间的关联仍存在争议,但据我们所知,迄今为止,关于移植患者中T细胞表位编码区的数据很少。在当前的研究中,我们确定了21例慢性丙型肝炎的人类白细胞抗原(HLA)-A2阳性西班牙患者,14例免疫抑制的肝移植受者和7例具有免疫功能的对照。测定了丙氨酸氨基转移酶,天冬氨酸氨基转移酶,病毒载量和纤维化进展速度。在纤维化进展缓慢或快速的患者之间比较了HCV分离株的遗传距离和HCV非结构3蛋白(NS3-1393 LIFCHSKKK和NS3-1406 KLVALGINAV)的表位变异。与分离株相比,移植患者快速进展的分离株差异更大(P = .03),同义(dS)变异平均值更高(P = .02),有些在系统发育树中得以区分。进展缓慢的患者。与A3限制的NS3-1392表位相比,发现HLA-A2限制的NS3-1406表位的变异性更大(21个分离物中有20个与原型不同)(变异率分别为19%和1.25%)。在一部分移植患者中未检测到病毒肽的转移,但在三名接受随访的非移植患者中有两例很明显。在移植或非移植患者中,特定氨基酸变异与纤维化进展(缓慢或快速)之间没有相关性。当前研究的结果表明,1)我们的地理区域可能存在不同的HCV-1b菌株,2)免疫抑制似乎对HCV NS3-1406表位的氨基酸变异影响很小,并且3)随着时间的推移可能发生变异在非免疫抑制患者中更为频繁。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号